Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Svaks Biotech India Pvt Ltd07-01-2018
07-01-2018
Updates
Disclosure u/r 31 of SEBI (SAST) Regulation,2011 informing Release of Pledge received from Mr.Pravin Herlekar05-01-2018
Press Release / Media Release
Media Release : New CEP application filed for VET API range of product with EDQM - Europe02-01-2018
Meeting Of Board Of Directors Of The Company Is Scheduled To Be Held On January 06, 2018
Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, we would like to inform you that the Meeting of Board of Directors of the Company is scheduled to be held on January 06, 201829-12-2017
Updates
Intimation under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 201128-12-2017